Fundamental Analysis
15 / 100CRubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | -122.2% | +25.7% | 2 / 3 | -42.5% | -21.36 pp | -28.93 pp | -53.5% | 1.96 | — | 28,2 | −42,5% | −11,0 | −122,2% | — | -1.28 | — |
| Pts | 0 | 4 | 8 | 0 | 0 | 0 | 0 | -4 | 8 | |||||||
Valuation annotation:Price: 3.700 (close price on 2026-09-10)EPS (TTM): −1.259,2
Financial charts
1.Revenue & growth
VND bn28,2Q2/26
1.Revenue & growth
VND bn28,2Q2/26
2.Profit & growth
VND bn-11,0Q2/26
3.Profit mix (Penman)
VND bn-26,4Q2/26
4.Margins & cost structure
%-4.5%Q2/26
5.Returns & cash cycle
% · days-17.4%Q2/26
6.Earnings quality & cash
VND bn-25,3Q2/26
7.Asset structure
VND bn183Q2/26
8.Funding & debt health
VND bn · times183Q2/26
9.Revenue backlog
VND bn3,08Q2/26
10.Valuation
times · %-2,9×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-525Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
No comparable quarter a year earlier
Quarters at 25%+ growth
1/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26